We are monitoring the impact of COVID-19 on APAC Non-Invasive Prenatal Testing Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 2703
Share on
Share on

Asia Pacific Non-Invasive Prenatal Testing Market Research Report - Segmented By Instruments, Method, Application, End User, & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis, Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 2703
Pages: 140

APAC Non-Invasive Prenatal Testing Market Size (2020 to 2025)

The size of the Non-Invasive Prenatal Testing Market was valued at USD 0.39 Billion in 2020. It is further projected to be growing at a CAGR of 20.3% and worth USD 0.98 billion by 2025.

During pregnancy, fetal DNA is freely circulating through the mother’s blood and is known as cell-free DNA (cf-DNA). The analysis of this cf-DNA is one of the methods of Non-Invasive Prenatal Testing.

Non-Invasive Prenatal Testing, also known as Non-Invasive Prenatal Screening, is the latest development in genetic testing that screens a mother’s blood during pregnancy and accurately identify the most common genetic disorders Syndrome, Patau Syndrome, and Edward Syndrome. Among its other uses is the gender determination of a baby.

The growth of the Asia-Pacific Non-Invasive Prenatal Testing Market is mainly driven by factors such as the high prevalence of genetic disorders distributed in a huge population base, growing awareness about genetic abnormalities, leaps in technological advancements, and the customer preference for non-invasive techniques over invasive ones. Low clinical validity of Non-Invasive Prenatal Testing results is one of the major constraints of the market.

This research report on the Asia Pacific Non-Invasive Prenatal Testing Market has been segmented and sub-segmented into the following categories.

By Instruments: 

  • Ultrasound
  • NGS
  • PCR
  • Microarray

By Method: 

  • FCMB
  • Cf-DNA

By Application: 

  • Trisomy
  • Microdeletion
  • Genetics
  • Rh Factor

By End User: 

  • Hospitals
  • Diagnostic Labs

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Key players operating in the Asia Pacific Non-Invasive Prenatal Testing Market profiled in this report are GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Pacific Biosciences of California, Inc. (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (U.S.), and Beijing Genomics Institute (China).

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Instruments                               

                                5.1.1 Introduction           

                                5.1.2 PCR            

                                5.1.3 Ultrasound              

                                5.1.4 NGS           

                                5.1.5 Microarray              

                                5.1.6  Y-o-Y Growth Analysis, By Instruments     

                                5.1.7  Market Attractiveness Analysis, By Instruments   

                                5.1.8  Market Share Analysis, By Instruments     

                5.2 Method                       

                                5.2.1 Introduction           

                                5.2.2 FCMB        

                                5.2.3 Cell-Free DNA (cf-DNA)     

                                5.2.4 Y-o-Y Growth Analysis, By Method               

                                5.2.5 Market Attractiveness Analysis, By Method             

                                5.2.6 Market Share Analysis, By Method              

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Trisomy    

                                5.3.3 Microdeletion        

                                5.3.4 Genetics  

                                5.3.5 Rh factor  

                                5.3.6 Y-o-Y Growth Analysis, By Application         

                                5.3.7  Market Attractiveness Analysis, By Application      

                                5.3.8  Market Share Analysis, By Application       

                5.4 End User                      

                                5.4.1 Introduction           

                                5.4.2 Hospital    

                                5.4.3 Diagnostic Labs      

                                5.4.4 Y-o-Y Growth Analysis, By End User             

                                5.4.5  Market Attractiveness Analysis, By End User          

                                5.4.6  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Instruments

                                                6.1.3.3 By Method

                                                6.1.3.4 By Application

                                                6.1.3.5 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Instruments

                                                6.1.4.3 By Method

                                                6.1.4.4 By Application

                                                6.1.4.5 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Instruments

                                                6.1.5.3 By Method

                                                6.1.5.4 By Application

                                                6.1.5.5 By End User

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 GE Healthcare                           

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Koninklijke Philips N.V                           

                8.3 Thermo Fisher Scientific                        

                8.4 Hoffman-La Roche                  

                8.5 Pacific Biosciences of California                          

                8.6 PerkinElmer                               

                8.7 QIAGEN N.V                               

                8.8 Agilent Technologies                              

                8.9 Beijing Genomics Institute                   

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Non-Invasive Prenatal Testing Market, By Instruments, From 2020 to 2025 (USD Million)
  2. Asia-Pacific Ultrasound Market, By Region, From 2020 to 2025 (USD Million)
  3. Asia-Pacific NGS Market, By Region, From 2020 to 2025 (USD Million)
  4. Asia-Pacific PCR Market, By Region, From 2020 to 2025 (USD Million)
  5. Asia-Pacific Microarray Market, By Region, From 2020 to 2025 (USD Million)
  6. Asia-Pacific Non-Invasive Prenatal Testing Market, By Method, From 2020 to 2025 (USD Million)
  7. Asia-Pacific FCMB Market, By Region, From 2020 to 2025 (USD Million)
  8. Asia-Pacific cf-DNA Market, By Region, From 2020 to 2025 (USD Million)
  9. Asia-Pacific Non-Invasive Prenatal Testing Market, By Application, From 2020 to 2025 (USD Million)
  10. Asia-Pacific Trisomy Market, By Region, From 2020 to 2025 (USD Million)
  11. Asia-Pacific Microdeletion Market, By Region, From 2020 to 2025 (USD Million)
  12. Asia-Pacific Genetics Market, By Region, From 2020 to 2025 (USD Million)
  13. Asia-Pacific Rh Factor Market, By Region, From 2020 to 2025 (USD Million)
  14. Asia-Pacific Non-Invasive Prenatal Testing Market, By End User, From 2020 to 2025 (USD Million)
  15. Asia-Pacific Hospital Market, By Region, From 2020 to 2025 (USD Million)
  16. Asia-Pacific Diagnostic Labs Market, By Region, From 2020 to 2025 (USD Million)
  17. Japan Non-Invasive Prenatal Testing Market, By Instruments, From 2020 to 2025 (USD Million)
  18. Japan Non-Invasive Prenatal Testing Market, By Method, From 2020 to 2025 (USD Million)
  19. Japan Non-Invasive Prenatal Testing Market, By Application, From 2020 to 2025 (USD Million)
  20. Japan Non-Invasive Prenatal Testing Market, By End User, From 2020 to 2025 (USD Million)
  21. China Non-Invasive Prenatal Testing Market, By Instruments, From 2020 to 2025 (USD Million)
  22. China Non-Invasive Prenatal Testing Market, By Method, From 2020 to 2025 (USD Million)
  23. China Non-Invasive Prenatal Testing Market, By Application, From 2020 to 2025 (USD Million)
  24. China Non-Invasive Prenatal Testing Market, By End User, From 2020 to 2025 (USD Million)
  25. India Non-Invasive Prenatal Testing Market, By Instruments, From 2020 to 2025 (USD Million)
  26. India Non-Invasive Prenatal Testing Market, By Method, From 2020 to 2025 (USD Million)
  27. India Non-Invasive Prenatal Testing Market, By Application, From 2020 to 2025 (USD Million)
  28. India Non-Invasive Prenatal Testing Market, By End User, From 2020 to 2025 (USD Million)
  29. Australia Non-Invasive Prenatal Testing Market, By Instruments, From 2020 to 2025 (USD Million)
  30. Australia Non-Invasive Prenatal Testing Market, By Method, From 2020 to 2025 (USD Million)
  31. Australia Non-Invasive Prenatal Testing Market, By Application, From 2020 to 2025 (USD Million)
  32. Australia Non-Invasive Prenatal Testing Market, By End User, From 2020 to 2025 (USD Million)
  33. South Korea Non-Invasive Prenatal Testing Market, By Instruments, From 2020 to 2025 (USD Million)
  34. South Korea Non-Invasive Prenatal Testing Market, By Method, From 2020 to 2025 (USD Million)
  35. South Korea Non-Invasive Prenatal Testing Market, By Application, From 2020 to 2025 (USD Million)
  36. South Korea Non-Invasive Prenatal Testing Market, By End User, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample